Agenda Subject to Change

Saturday, June 28, 2025

7:45       Welcome / Opening Remarks

Mandeep Bajaj, MD, FRCP
Professor of Medicine, Baylor College of Medicine, Houston

8:00       GLP-1 Receptor Agonists in Type 2 Diabetes

Ralph DeFronzo, MD
Professor of Medicine, The University of Texas Health Science Center at San Antonio

9:00      SGLT-2 Inhibitors and Chronic Kidney Disease in Type 2 Diabetes

Sankar Navaneethan, MD, MS, MPH
Professor of Medicine, Baylor College of Medicine, Houston

10:00   Break

10:10     Diabetes and Heart Failure

Biykem Bozkurt, MD, PhD, FHFSA, FACC, FAHA, FESC
Professor of Medicine, Baylor College of Medicine, Houston

11:00    Cardiovascular Risk Reduction in Type 2 Diabetes

Vijay Nambi, MD, PhD
Professor of Medicine, Baylor College of Medicine, Houston

11:50   Break

12:30    Newer Insulins

Shahid Muhammad, MD
Staff Endocrinologist, Kelsey-Seybold Clinic, Houston

1:15      Weight Management in Patients with Type 2 Diabetes

Osama Hamdy, MD, PhD
Associate Professor of Medicine, Harvard Medical School, Boston

2:00    Diet and Diabetes

Dulce Garcia, MS, RDN, CDCES
Diabetes Educator, Baylor College of Medicine, Houston

3:00    Break

3:10      Managing Diabetes in Hospitalized Patients

Guillermo Umpierrez, MD, CDE, FACP, FACE
Professor of Medicine, Emory University, Atlanta

4:10      Insulin Pumps and Continuous Glucose Monitoring Systems

Celia Levesque, RN, MSN, CNS-BC, NP-C, BC-ADM, CDCES
Advanced Practice Nurse, The University of Texas MD Anderson Cancer Center, Houston

5:10      Q&A / Evaluations

Mandeep Bajaj, MD, FRCP

5:30     Adjourn

Program Overview

The 18th Annual Diabetes Symposium is a 1-day virtual course. The purpose of this symposium is to update health care providers with state-of-the-art information regarding evaluation and treatment of patients with diabetes. Information is constantly evolving, and physicians lack knowledge related to the most effective treatments for patients with diabetes as well as the role of newer treatments in preventing cardiovascular and renal complications of diabetes as per the guidelines published by the ADA. In addition, they should understand the use of SGLT2 inhibitors in patients with diabetes and heart failure, newer strategies for weight loss in obese patient, and the management of diabetes in hospitalized patients including the use of continuous glucose monitors. The symposium will also address new diabetes technology for insulin delivery and understand the advantages (e.g., reduction in hypoglycemia) with newer technology and insulin formulations. Physicians should effectively identify the adverse effects of diabetes therapies and identify additional practice gaps that should be addressed in the future.

Target Audience

For this symposium, the target audience is endocrinologists, cardiologists, primary care physicians, cardiovascular surgeons, family and general practitioners, nurses, nurse practitioners, dietitians and physician assistants. We will update health care providers with state-of-the-art information regarding evaluation and treatment of patients with diabetes.

Learning Objectives

At the conclusion of this symposium, participants should be able to:

• Describe novel and optimal therapies for treatment of type 2 diabetes.
• Discuss and generate evidence-based treatment strategies for management of type 2 diabetes based on recently published clinical trials regarding cardiovascular and renal outcomes with SGLT-2 inhibitors and GLP-1 receptor agonists.
• Explain comprehensive strategies for cardiovascular risk reduction in type 2 diabetes.
• Describe the role of newer insulins in the management of diabetes.
• Incorporate effective weight reduction treatments in the management of obese patients with type 2 diabetes.
• Develop and implement effective strategies for the management of hyperglycemia in hospitalized patients.

Accreditation

The Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The Texas Heart Institute designates this live activity for a maximum of 8.75 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Credit

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.75 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Successful completion is a passing grade of 70% on the assessment in the CME evaluation.

The deadline to complete the MOC section of the CME evaluation is 2 weeks after the day of the symposium.

Approved Provider Unit (APU) Statement

CHI St. Luke’s Health Baylor St. Luke’s Medical Center is approved as a provider of nursing continuing professional development by the Louisiana State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. LSNA Provider No. 4002068.

Dietitian credits will be available.

Click Here Register Now

Registration Fees

Physicians (MD, DO) – $300.00
Nurses/Nurse Practitioners – $175.00
Non-Physicians* – $175.00
Fellows/Residents – $150.00
Medical Students – $50.00
Industry – $400.00

BSLMC** Physicians – $150.00
BSLMC Nurses/Nurse Practitioners – $50.00
BSLMC Non-Physicians* – $50.00
BSLMC Fellows/Residents – $50.00

*Physician Assistants, Dietitians, Health Care Professionals
**Baylor St. Luke’s Medical Center

Cancellation Policy

The Texas Heart Institute Office of CME must receive written notification of a refund request postmarked and dated no later than Friday, June 20, 2025.

A $50.00 processing fee will be assessed for each cancellation. Refunds cannot be made for those who register but do not attend the scheduled activities. Refunds will not be provided for cancellations made within 48 hours of the symposium. The Texas Heart Institute reserves the right to cancel this activity if registration is deemed insufficient.

The symposium will be held virtually on Zoom.